Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type I-Allergy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01912456
What this trial is testing

Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 90
Testing effectiveness (Phase 2)Study completedNCT01576523
What this trial is testing

Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 18
Not applicableStudy completedNCT01467063
What this trial is testing

Glutamine and Insulin Sensitivity in Type I Diabetes

Who this might be right for
Type I Diabetes Mellitus
Nemours Children's Clinic 13
Large-scale testing (Phase 3)Study completedNCT05259917
What this trial is testing

A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 136
Post-approval studies (Phase 4)Study completedNCT01467947
What this trial is testing

Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 46
Large-scale testing (Phase 3)Not Yet RecruitingNCT06909006
What this trial is testing

Semaglutide Treatment in Type 1 Diabetes

Who this might be right for
Obesity in DiabetesObesity/TherapyType 1 Diabetes Mellitus (T1DM)+6 more
Nordsjaellands Hospital 122
Early research (Phase 1)Study completedNCT04496089
What this trial is testing

Evaluation of Safety, Biodistibution and Sensitivity/Specificity of PET/CT Imaging With 89Zr-TLX250 in Subjects With RCC

Who this might be right for
Carcinoma, Renal CellClear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 6
Early research (Phase 1)Study completedNCT00116285
What this trial is testing

Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 12
Not applicableStudy completedNCT01407640
What this trial is testing

Diagnosis and Physiopathology of Insulin Allergy

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Hypersensitivity+2 more
Assistance Publique - Hôpitaux de Paris 55
Testing effectiveness (Phase 2)Looking for participantsNCT07699380
What this trial is testing

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

Who this might be right for
Type 1 Diabetes (T1D)Metabolic DiseasesGlucose Metabolism Disorders+6 more
University of Washington 60
Testing effectiveness (Phase 2)Ended earlyNCT05047185
What this trial is testing

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 34
Not applicableEnded earlyNCT05961163
What this trial is testing

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study

Who this might be right for
Coronary DiseaseMyocardial InfarctionHeart Failure+13 more
Universitätsklinikum Hamburg-Eppendorf 61
Not applicableStudy completedNCT05596656
What this trial is testing

IgE-mediated Allergies Among Type 1 Diabetes Mellitus Children, Single Centre Observational Study

Who this might be right for
Diabetic Children
Mansoura University Children Hospital 90
Not applicableUnknownNCT05932953
What this trial is testing

Skin Tolerance of Medical Devices for Diabetes Monitoring and Treatment in Children With Type 1 Diabetes

Who this might be right for
Cutaneous AllergyDiabetes Mellitus, Type 1Atopic Disorders
Central Hospital, Nancy, France 400
Not applicableStudy completedNCT06890208
What this trial is testing

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave

Who this might be right for
Coronary DiseaseMyocardial InfarctionHeart Failure+13 more
Universitätsklinikum Hamburg-Eppendorf 176
Testing effectiveness (Phase 2)UnknownNCT04620954
What this trial is testing

Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin

Who this might be right for
Epithelial Ovarian Cancer
National Cancer Centre, Singapore 31
Not applicableStudy completedNCT01291381
What this trial is testing

Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children

Who this might be right for
Allergic RhinitisEffects of Immunotherapy
Beijing Tongren Hospital 50
Very early researchStudy completedNCT03594565
What this trial is testing

The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case Series

Who this might be right for
T1DMHypersensitivity
Assaf-Harofeh Medical Center 13
Not applicableStudy completedNCT02490124
What this trial is testing

The Effect of Type 1 Diabetes on Pan-Arterial Vascular Function and Insulin Sensitivity in Humans

Who this might be right for
Diabetes Type 1
University of Virginia 7
Testing effectiveness (Phase 2)WithdrawnNCT05035368
What this trial is testing

Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes

Who this might be right for
Type I Diabetes
Dompé Farmaceutici S.p.A
Next Page